Search hospitals

>

South Carolina

>

Greenville

Prisma Health Greenville Memorial Hospital

Claim this profile

Greenville, South Carolina 29605

Global Leader in Lung Cancer

Global Leader in Cancer

Conducts research for Breast Cancer

Conducts research for Non-Small Cell Lung Cancer

Conducts research for Pancreatic Cancer

424 reported clinical trials

38 medical researchers

Photo of Prisma Health Greenville Memorial Hospital in GreenvillePhoto of Prisma Health Greenville Memorial Hospital in GreenvillePhoto of Prisma Health Greenville Memorial Hospital in Greenville

Summary

Prisma Health Greenville Memorial Hospital is a medical facility located in Greenville, South Carolina. This center is recognized for care of Lung Cancer, Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Pancreatic Cancer and other specialties. Prisma Health Greenville Memorial Hospital is involved with conducting 424 clinical trials across 746 conditions. There are 38 research doctors associated with this hospital, such as Ki Chung, MD, Aniket Saha, Jeffrey K. Giguere, and Michael J Wagner, MD.

Area of expertise

1

Lung Cancer

Global Leader

Prisma Health Greenville Memorial Hospital has run 52 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
Stage III
Stage I
2

Cancer

Global Leader

Prisma Health Greenville Memorial Hospital has run 50 trials for Cancer. Some of their research focus areas include:

Stage IV
Stage I
Stage III

Top PIs

Clinical Trials running at Prisma Health Greenville Memorial Hospital

Bladder Cancer

Cancer

Lung Cancer

Ovarian Cancer

Breast Cancer

Heart Failure

Breast cancer

Prostate Cancer

Colorectal Cancer

Multiple Myeloma

Image of trial facility.

Gemcitabine + Docetaxel vs BCG

for Bladder Cancer

This trial is testing whether a combination of two drugs, Gemcitabine and Docetaxel, given directly into the bladder, is effective for patients with high-grade non-muscle invasive bladder cancer who have not been treated with the standard therapy before. The goal is to see if this new treatment can prevent cancer from coming back or spreading. The study will also look at the quality of life, safety, and side effects of the new treatment. Gemcitabine and Docetaxel have shown promise as an alternative treatment, especially in cases where the standard therapy fails or is not tolerated.

Recruiting

2 awards

Phase 3

14 criteria

Image of trial facility.

Gemcitabine + Cisplatin

for Bladder Cancer

This phase II trial studies how well gemcitabine hydrochloride and cisplatin work in treating participants with invasive bladder urothelial cancer. Drugs used in chemotherapy, such as gemcitabine hydrochloride and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.

Recruiting

1 award

Phase 2

Image of trial facility.

Blood Sample Collection

for Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.

Recruiting

1 award

N/A

9 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Prisma Health Greenville Memorial Hospital?

Where is Prisma Health Greenville Memorial Hospital located?

Who should I call to ask about financial aid or insurance network?

What insurance does Prisma Health Greenville Memorial Hospital accept?

What awards or recognition has Prisma Health Greenville Memorial Hospital received?